Amyloidosis trials in Germany

In Germany 33 Also abroad 185

21 of 33 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Essen Amyloidosis Registry
Where
Essen
Age
18 years and over
People
400
Run by
University Hospital, Essen
See details and how to joinNCT06887283
No phaseTaking people
Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis
Where
Bonn, München
Age
18 years and over
People
2,200 worldwide
Run by
Idoven 1903 S.L.
See details and how to joinNCT06978660
No phaseNot yet taking people in Germany
Single-arm, Multi-center Study Evaluating the Acceptance and Feasibility of a Digital Remote Monitoring Tool Configured for Patients With ATTR-CM: ACO-Monitor
Where
Heidelberg
Age
18 years and over
People
60 worldwide
Run by
Bayer
See details and how to joinNCT07557147
No phaseTaking people
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Where
Berlin, Giessen, Hanover
People
1,500 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT04561518
No phaseTaking people
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
Where
Heidelberg, Munich, Münster, Würzburg
Age
18 years and over
People
2,000 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT07358078
No phaseTaking people
Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
Where
Münster
People
10 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT05040373
No phaseTaking people
A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
Where
Multiple Locations
Age
18 years and over
People
2,000 worldwide
Run by
Bayer
See details and how to joinNCT07235462
No phaseTaking people
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Where
Aachen, Berlin, Cologne, Frankfurt am Main, Hanover, Homburg, Mainz, Würzburg
Age
18 years to 130 years
People
1,850 worldwide
Run by
AstraZeneca
See details and how to joinNCT06465810
No phaseTaking people
Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations
Where
Hanover
Age
18 years and over
People
320 worldwide
Run by
AstraZeneca
See details and how to joinNCT07654855
No phaseTaking people
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
Where
Berlin
People
52,121 worldwide
Run by
AstraZeneca
See details and how to joinNCT06355934
No phaseTaking people
Non-Interventional Study on the Prevalence of Cardiac Amyloidosis in Patients With Higher-Grade Aortic Valve Stenosis - Evaluation Using Echocardiography, Computed Tomography, Tc99-SPECT/CT and Cardiac Magnetic Resonance Imaging (CMR)
Where
Tübingen
Age
18 years and over
People
600
Run by
University Hospital Tuebingen
See details and how to joinNCT07752732
No phaseTaking people
The Eplontersen Pregnancy and Lactation Outcomes Study
Where
Frankfurt
People
10
Run by
AstraZeneca
See details and how to joinNCT07205666
No phaseTaking people
Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
Where
Berlin, Essen, Frankfurt am Main, Würzburg
Age
18 years and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07690436
No phaseNot yet taking people in Germany
Screening, Characterization, and Longitudinal Follow-up of Patients With Cardiac Amyloidosis
Where
Düsseldorf
Age
18 years and over
People
200
Run by
Heinrich-Heine University, Duesseldorf
See details and how to joinNCT07577466
No phaseTaking people
A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)
Where
Heidelberg
Age
18 years to 99 years
People
400 worldwide
Run by
Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT06205953
No phaseTaking people
Multimodal Analysis of Endomyocardial Biopsies
Where
Essen
Age
18 years and over
People
216
Run by
University Hospital, Essen
See details and how to joinNCT07359690
No phaseTaking people
Hybrid Florbetaben PET/MRI for Imaging of Cardiac Amyloidosis
Where
Essen
Age
40 years and over
People
25
Run by
University Hospital, Essen
See details and how to joinNCT07154381
No phaseTaking people
Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease
Where
Essen
Age
18 years and over
People
15
Run by
University Hospital, Essen
See details and how to joinNCT07154394
No phaseTaking people
A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.
Where
Frankfurt am Main, Munich
Age
18 years and over
People
600 worldwide
Run by
Medical University of Vienna
See details and how to joinNCT06836011
No phaseTaking people
DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies
Where
Heidelberg
Age
18 years to 80 years
People
2,040
Run by
University Hospital Heidelberg
See details and how to joinNCT04265040
No phaseTaking people
Cardiac Amyloidosis Registry of University Hospital Leipzig
Where
Leipzig
People
500
Run by
University of Leipzig
See details and how to joinNCT06129656